USPTO Assignments on the Web

	United States Patent and Trademark Office
	Home\|Site Index\|Search\|Guides\|Contacts\|eBusiness\|eBiz alerts\|News\|Help

Assignments on the Web > Patent Query

Patent Assignment Details

NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Reel/Frame:	061297/0990			Pages:	6
		Recorded:	08/22/2022
Attorney Dkt #:	HUDSON YARDS COA
Conveyance:	CHANGE OF ADDRESS

Total properties: 36

Patent #:	9611289	Issue Dt:	04/04/2017	Application #:	14120366	Filing Dt:	05/14/2014
Publication #:	US20140371190	Pub Dt:	12/18/2014
Title:	Farnesoid X receptor modulators

Patent #:	11034717	Issue Dt:	06/15/2021	Application #:	15288390	Filing Dt:	10/07/2016
Publication #:	US20170101434	Pub Dt:	04/13/2017
Title:	FARNESOID X RECEPTOR MODULATORS

Patent #:	10258633	Issue Dt:	04/16/2019	Application #:	15299559	Filing Dt:	10/21/2016
Publication #:	US20170165277	Pub Dt:	06/15/2017
Title:	TREATMENT OF FIBROSIS USING FXR LIGANDS

Patent #:	10369160	Issue Dt:	08/06/2019	Application #:	15484379	Filing Dt:	04/11/2017
Publication #:	US20170296556	Pub Dt:	10/19/2017
Title:	METHODS OF TREATING CANCER

Patent #:	11311557	Issue Dt:	04/26/2022	Application #:	15548537	Filing Dt:	08/03/2017
Publication #:	US20180008616	Pub Dt:	01/11/2018
Title:	PHARMACEUTICAL COMPOSITIONS FOR COMBINATION THERAPY

Patent #:	10894054	Issue Dt:	01/19/2021	Application #:	15564799	Filing Dt:	10/06/2017
Publication #:	US20180117065	Pub Dt:	05/03/2018
Title:	FXR AGONIST COMPOSITIONS FOR COMBINATION THERAPY

Patent #:	10421772	Issue Dt:	09/24/2019	Application #:	15645136	Filing Dt:	07/10/2017
Publication #:	US20190300564	Pub Dt:	10/03/2019
Title:	STEROIDS AS AGONISTS FOR FXR

Patent #:	NONE	Issue Dt:		Application #:	15652777	Filing Dt:	07/18/2017
Publication #:	US20180064729	Pub Dt:	03/08/2018
Title:	Treatment of Pulmonary Disease

Patent #:	NONE	Issue Dt:		Application #:	15711205	Filing Dt:	09/21/2017
Publication #:	US20180256600	Pub Dt:	09/13/2018
Title:	METHODS OF TREATING CANCER

Patent #:	10800807	Issue Dt:	10/13/2020	Application #:	15742595	Filing Dt:	09/26/2018
Publication #:	US20190284225	Pub Dt:	09/19/2019
Title:	TGR5 MODULATORS AND METHODS OF USE THEREOF

Patent #:	10414791	Issue Dt:	09/17/2019	Application #:	15748716	Filing Dt:	01/30/2018
Publication #:	US20190010184	Pub Dt:	01/10/2019
Title:	METHODS FOR PREPARATION OF BILE ACIDS AND DERIVATIVES THEREOF

Patent #:	11072631	Issue Dt:	07/27/2021	Application #:	15762781	Filing Dt:	03/23/2018
Publication #:	US20200239515	Pub Dt:	07/30/2020
Title:	METHODS AND INTERMEDIATES FOR THE PREPARATION BILE ACID DERIVATIVES

Patent #:	10604545	Issue Dt:	03/31/2020	Application #:	15773620	Filing Dt:	05/04/2018
Publication #:	US20190062367	Pub Dt:	02/28/2019
Title:	METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF

Patent #:	11066437	Issue Dt:	07/20/2021	Application #:	16016486	Filing Dt:	06/22/2018
Publication #:	US20180371009	Pub Dt:	12/27/2018
Title:	METHODS AND INTERMEDIATES FOR THE PREPARATION OF BILE ACID DERIVATIVES

Patent #:	10646499	Issue Dt:	05/12/2020	Application #:	16030141	Filing Dt:	07/09/2018
Publication #:	US20190076446	Pub Dt:	03/14/2019
Title:	COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

Patent #:	11419878	Issue Dt:	08/23/2022	Application #:	16089274	Filing Dt:	09/27/2018
Publication #:	US20190247404	Pub Dt:	08/15/2019
Title:	Medicine Obtained by Combining FXR Agonist and ARB

Patent #:	11413295	Issue Dt:	08/16/2022	Application #:	16089477	Filing Dt:	09/28/2018
Publication #:	US20190216826	Pub Dt:	07/18/2019
Title:	ORAL PREPARATION OF OBETICHOLIC ACID

Patent #:	11331273	Issue Dt:	05/17/2022	Application #:	16089544	Filing Dt:	09/28/2018
Publication #:	US20200268671	Pub Dt:	08/27/2020
Title:	FILM-COATED TABLET HAVING HIGH CHEMICAL STABILITY OF ACTIVE INGREDIENT

Patent #:	10550146	Issue Dt:	02/04/2020	Application #:	16094535	Filing Dt:	10/18/2018
Publication #:	US20190211052	Pub Dt:	07/11/2019
Title:	METHODS FOR THE PREPARATION OF OBETICHOLIC ACID AND DERIVATIVES THEREOF

Patent #:	10532061	Issue Dt:	01/14/2020	Application #:	16124139	Filing Dt:	09/06/2018
Publication #:	US20190209586	Pub Dt:	07/11/2019
Title:	FARNESOID X RECEPTOR MODULATORS

Patent #:	NONE	Issue Dt:		Application #:	16189559	Filing Dt:	11/13/2018
Publication #:	US20190153020	Pub Dt:	05/23/2019
Title:	Preparation and Uses of Obeticholic Acid

Patent #:	10987362	Issue Dt:	04/27/2021	Application #:	16228944	Filing Dt:	12/21/2018
Publication #:	US20200397803	Pub Dt:	12/24/2020
Title:	TREATMENT OF FIBROSIS USING FXR LIGANDS

Patent #:	NONE	Issue Dt:		Application #:	16337982	Filing Dt:	03/29/2019
Publication #:	US20200024299	Pub Dt:	01/23/2020
Title:	CRYSTALLINE FORMS OF A BILE ACID DERIVATIVE

Patent #:	NONE	Issue Dt:		Application #:	16486873	Filing Dt:	08/19/2019
Publication #:	US20200164005	Pub Dt:	05/28/2020
Title:	PHARMACEUTICAL COMPOSITIONS OF A BILE ACID DERIVATIVE AND MICROBIOME AND USES THEREOF

Patent #:	NONE	Issue Dt:		Application #:	16596216	Filing Dt:	10/08/2019
Publication #:	US20200046735	Pub Dt:	02/13/2020
Title:	COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	16596741	Filing Dt:	10/08/2019
Publication #:	US20200046736	Pub Dt:	02/13/2020
Title:	COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

Patent #:	NONE	Issue Dt:		Application #:	16597412	Filing Dt:	10/09/2019
Publication #:	US20200054650	Pub Dt:	02/20/2020
Title:	COMPOSITIONS OF OBETICHOLIC ACID AND METHODS OF USE

Patent #:	11472831	Issue Dt:	10/18/2022	Application #:	16632093	Filing Dt:	01/17/2020
Publication #:	US20200165290	Pub Dt:	05/28/2020
Title:	ISOTOPICALLY LABELED BILE ACID DERIVATIVES

Patent #:	11000532	Issue Dt:	05/11/2021	Application #:	16695528	Filing Dt:	11/26/2019
Publication #:	US20200297739	Pub Dt:	09/24/2020
Title:	FARNESOID X RECEPTOR MODULATORS

Patent #:	11345721	Issue Dt:	05/31/2022	Application #:	17010505	Filing Dt:	09/02/2020
Publication #:	US20210122779	Pub Dt:	04/29/2021
Title:	TGR5 MODULATORS AND METHODS OF USE THEREOF

Patent #:	NONE	Issue Dt:		Application #:	17142870	Filing Dt:	01/06/2021
Publication #:	US20210395293	Pub Dt:	12/23/2021
Title:	PREPARATION AND USES OF OBETICHOLIC ACID

Patent #:	NONE	Issue Dt:		Application #:	17211033	Filing Dt:	03/24/2021
Publication #:	US20210346400	Pub Dt:	11/11/2021
Title:	TREATMENT OF FIBROSIS USING FXR LIGANDS

Patent #:	NONE	Issue Dt:		Application #:	17228819	Filing Dt:	04/13/2021
Publication #:	US20210228599	Pub Dt:	07/29/2021
Title:	FARNESOID X RECEPTOR MODULATORS

Patent #:	NONE	Issue Dt:		Application #:	17320286	Filing Dt:	05/14/2021
Publication #:	US20210269475	Pub Dt:	09/02/2021
Title:	FARNESOID X RECEPTOR MODULATORS

Patent #:	NONE	Issue Dt:		Application #:	17428029	Filing Dt:	08/03/2021
Publication #:	US20220096495	Pub Dt:	03/31/2022
Title:	TREATMENT AND PREVENTION OF INTESTINAL INFLAMMATORY DISEASES WITH A BILE ACID DERIVATIVE

Patent #:	NONE	Issue Dt:		Application #:	17615186	Filing Dt:	11/30/2021
Publication #:	US20220226350	Pub Dt:	07/21/2022
Title:	PHARMACEUTICAL COMPOSITIONS COMPRISING A FXR AGONIST AND A FIBRATE FOR USE IN THE TREATMENT OF CHOLESTATIC LIVER DISEASE

Assignor

INTERCEPT PHARMACEUTICALS, INC.

Exec Dt:

08/18/2022

Assignee

INTERCEPT PHARMACEUTICALS, INC.

305 MADISON AVENUE

MORRISTOWN, NEW JERSEY 07960

Correspondence name and address
	INTERCEPT PHARMACEUTICALS, INC.
	305 MADISON AVENUE
	MORRISTOWN, NJ 07960

Search Results as of: 05/21/2024 10:25 AM

If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6

Web interface last modified: August 25, 2017 v.2.6